Beschreibung
Biomarker panels for systematic comparison of EPA and DHA biological effects are proposed for future clinical trial design.
Figure 32
Source Paper
Do Eicosapentaenoic Acid and Docosahexaenoic Acid Have the Potential to Compete against Each Other?Cite This Figure
![Figure 32: Biomarker panels for systematic comparison of EPA and DHA biological effects are proposed for future clinical trial design.]() > Source: Anandita Pal et al. "Do Eicosapentaenoic Acid and Docosahexaenoic Acid Have the Potential to Compete ." *Nutrients*, 2020. PMID: [33276463](https://pubmed.ncbi.nlm.nih.gov/33276463/)
<figure> <img src="" alt="Biomarker panels for systematic comparison of EPA and DHA biological effects are proposed for future clinical trial design." /> <figcaption>Figure 32. Biomarker panels for systematic comparison of EPA and DHA biological effects are proposed for future clinical trial design.<br> Source: Anandita Pal et al. "Do Eicosapentaenoic Acid and Docosahexaenoic Acid Have the Potential to Compete ." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33276463/">33276463</a></figcaption> </figure>